Skip to Main Content

Paper Details

A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition.
Cell Stem Cell
154
2013
BC, BC LSC, BC LSCS, BC LSCs, BCL2, BCL2 family, BCR-ABL, CML, LSCs, Leukemia, Leukemia stem cells, Pan-, blast crisis, bone-marrow-resident human leukemia stem cells, chronic myeloid leukemia, dormant LSCs, human, myeloid progenitors, normal progenitors, prosurvival BCL2 family genes, prosurvival BCL2 family proteins, sabutoclax, self-renewal and survival genes, stromal, tyrosine, tyrosine kinase, whole

Datasets